Table 2. Articles included in the ASH... | American Society of Hematology

Table 2.

Articles included in the ASH Health Equity Compendium, by manuscript topic

Authors	Journal	Year	Study summary	Study design	Study site	Disease	Disparities examined	SES measures
Basic science correlates of disparities
Hu et al¹	Blood	2018	Genetic determinants of racial disparities in vitamin B12 levels	Basic science	n/a	Hematopoiesis	Race/ethnicity	n/a
Qian et al²	Blood	2019	Genetic basis for racial disparities in ALL	Basic science	n/a	Hematologic malignancy	Race/ethnicity	n/a
Fillmore et al³	Blood Advances	2021	Genetic basis for racial disparities in multiple myeloma	Basic science	n/a	Hematologic malignancy	Race/ethnicity	n/a
Mittelman et al⁴	Blood	2021	Genetic basis for racial disparities in ALL	Basic science	n/a	Hematologic malignancy	Race/ethnicity	n/a
Health equity in laboratory medicine
Merz et al⁵	Blood	2021	Appeal to stop labeling common phenotypes in non-White populations as abnormal	Perspective/editorial	n/a	Leukocytes, inflammation, immunology	Race/ethnicity	n/a
Merz et al⁶	Blood Advances	2023	Duffy-null phenotype is common among Black people and is associated with lower absolute neutrophil count	Prospective observational	Single center	Leukocytes, inflammation, immunology	Race/ethnicity	n/a
Bagheri et al⁷	Blood Advances	2023	Duffy-null phenotype is common among Black people and is associated with lower absolute neutrophil count	Retrospective	Single center	Leukocytes, inflammation, immunology	Race/ethnicity	n/a
Disease phenotype and outcome differences by patient demographics
Østgård et al⁸	Blood	2018	Association between cohabitation status, treatment, and outcome in patients with AML	Retrospective	Database	Hematologic malignancy	SES	Cohabitation, marital status
Goldstein et al⁹	Blood	2018	Disparities in survival by insurance status in follicular lymphoma	Retrospective	Database	Hematologic malignancy	SES	Insurance status
Ailawadhi et al¹⁰	Blood Advances	2019	Racial disparities in treatment patterns and outcomes among patients with multiple myeloma	Retrospective	Database	Hematologic malignancy	Race/ethnicity	n/a
Fillmore et al¹¹	Blood	2019	Racial differences in survival among patients with multiple myeloma	Retrospective	Database	Hematologic malignancy	Race/ethnicity, SES	Income
Zhang et al¹²	Blood Advances	2020	Impact of single parenthood on cardiopulmonary function in pediatric patients with sickle cell anemia	Prospective observational	Multicenter	Red cell physiology and disorders	SES	Single-parent household
Kim et al¹³	Blood	2020	Racial differences in ITP prevalence and phenotype	Retrospective	Multicenter	Hemostasis, thrombosis, vascular wall biology	Race/ethnicity	n/a
Conneely et al¹⁴	Blood Advances	2021	Racial/ethnic disparities in clinical phenotype, genetics, and survival in pediatric AML	Retrospective	Database	Hematologic malignancy	Race/ethnicity	n/a
Yao et al¹⁵	Blood Advances	2021	Disparities in skeletal toxicity among patients with childhood ALL	Retrospective	Single center	Hematologic malignancy	Race/ethnicity	n/a
Glimelius et al¹⁶	Blood Advances	2021	Marital status affects transplant access and survival for patients with mantel cell lymphoma	Retrospective	Database	Hematologic malignancy	SES	Marital status
Bona et al¹⁷	Blood	2021	Neighborhood poverty and pediatric allogeneic transplant outcomes	Retrospective	Database	BMT and cell therapies	Race/ethnicity, SES	Neighborhood poverty, insurance status
Milrod et al¹⁸	Blood	2021	Skin hyperpigmentation in Black patients receiving treatment with immunomodulatory drugs	Retrospective	Single center	BMT/cell therapies	Race/ethnicity	n/a
Van der Meulen et al¹⁹	Hematology, ASH Education Program	2022	Review of the impact of von Willebrand disease on women	Review	n/a	Hemostasis, thrombosis, vascular wall biology	Gender	n/a
Peres et al²⁰	Blood Advances	2022	Racial disparities in clonal hematopoiesis, tumor markers, and outcomes in patients with multiple myeloma	Retrospective	Single center	Hematologic malignancy	Race/ethnicity	n/a
Datta et al²¹	Blood Advances	2022	Racial disparities in cancer-associated thrombosis	Retrospective	Database	Hemostasis, thrombosis, vascular wall biology	Race/ethnicity	n/a
Faruqi et al²²	Blood Advances	2022	Racial/ethnic disparities in CAR T-cell therapy outcomes	Retrospective	Single center	BMT/cell therapies	Race/ethnicity	n/a
Chaturvedi et al²³	Blood	2022	Racial disparities in relapse risk and response to rituximab in patients with TTP	Retrospective	Multicenter	Hemostasis, thrombosis, vascular wall biology	Race/ethnicity	n/a
Abraham et al²⁴	Blood	2022	Structural racism is a mediator of disparities in AML outcomes	Retrospective	Multicenter	Hematologic malignancy	Race/ethnicity, SES	Structural racism, insurance status
Kittai et al²⁵	Blood Advances	2023	Racial and socioeconomic disparities in CLL/SLL	Retrospective	Database	Hematologic malignancy	Race/ethnicity, SES	Neighborhood poverty
Larkin et al²⁶	Blood Advances	2022	Racial disparities in early death rates, treatment resistance, and survival in Black adolescents and young adults with AML	Retrospective	Multicenter	Hematologic malignancy	Race/ethnicity	n/a
Gangat et al²⁷	Blood Advances	2023	Racial disparities in myelofibrosis phenotype and survival	Retrospective	Multicenter	Hematologic malignancy	Race/ethnicity	n/a
Newman et al²⁸	Blood	2023	Impact of poverty on outcomes for children treated with CD19-directed CAR T-cell therapy	Retrospective	Single center	BMT and cell therapies	Race/ethnicity, SES	Neighborhood poverty, insurance status
Access to care for underserved populations
Bhatt et al²⁹	Blood Advances	2018	Socioeconomic status disparities in treatment patterns among patients with newly diagnosed AML	Retrospective	Database	Hematologic malignancy	Race/ethnicity, SES	Insurance status, median household income
Husson et al³⁰	Blood	2018	Review of unique barriers affecting care delivery and outcomes for adolescents and young adults with hematologic malignancies	Review	n/a	Hematologic malignancy	Age, SES	Education, employment, and financial challenges, social relationship
Keegan et al³¹	Hematology, ASH Education Program	2018	Disparities in clinical trial enrollments for adolescent patients	Review	n/a	n/a	Age, race/ethnicity, SES	Insurance status
Franceschi et al³²	Blood	2019	Access to emergency departments for acute events and identification of sickle cell disease in refugees	Retrospective	Multicenter	Red cell physiology and disorders	Immigration status	n/a
Chino et al³³	Blood Advances	2019	Disparities in place of death for patients with hematologic malignancies	Retrospective	Database	Hematologic malignancy	Race/ethnicity, SES	Marital status, education level
Barker et al³⁴	Blood Advances	2019	Racial disparities in access to HLA-matched unrelated donor transplants	Prospective observational	Single center	BMT/cell therapies	Race/ethnicity	n/a
Webb et al³⁵	Hematology, ASH Education Program	2020	Review of the social aspects of chronic transfusion support	Review	n/a	n/a	SES	Social determinants of health, health literacy
Buchbinder et al³⁶	Hematology, ASH Education Program	2021	Review of psychosocial and financial issues after hematopoietic cell transplantation	Review	n/a	BMT/cell therapies	SES	Social/financial barriers
Hong et al³⁷	Hematology, ASH Education program	2021	Review of access to allogeneic transplantation according to race, geography, and socioeconomics	Review	n/a	BMT/cell therapies	Race/ethnicity, SES	Insurance, education, poverty, employment
Teichman et al³⁸	Blood Advances	2021	Socioeconomic disparities in iron deficiency screening in pregnancy	Retrospective	Database	Red cell physiology and disorders	SES	Neighborhood poverty
Fingrut et al³⁹	Blood Advances	2022	Racial disparities in access to optimal alternative donor allografts	Retrospective	Single center	BMT/cell therapies	Race/ethnicity	n/a
Hussaini et al⁴⁰	Blood Advances	2022	Rural-urban disparities in place of death among patients with hematologic malignancies	Retrospective	Database	Hematologic malignancy	Geographic	n/a
Fingrut et al⁴¹	Blood Advances	2023	Racial disparities in time to allogeneic transplantation	Retrospective	Single center	Hematologic malignancy	Race/ethnicity	n/a
Wolfson et al⁴²	Blood Advances	2023	Neighborhood poverty, health status, and health use after stem cell transplantation	Retrospective	Multicenter	BMT/cell therapies	SES	Neighborhood poverty, annual household income, education
Diversity, equity, and inclusion in clinical trials enrollment
Hantel et al⁴³	Blood Advances	2021	Racial/ethnic disparities in enrollment and demographic reporting requirements in acute leukemia clinical trials	Meta-analysis	Database	Hematologic malignancy	Race/ethnicity	n/a
Kanapuru et al⁴⁴	Blood Advances	2022	Racial/ethnic disparities in multiple myeloma US FDA approval trials	Meta-analysis	Database	Hematologic malignancy	Race/ethnicity	n/a
Muffly et al⁴⁵	Blood Advances	2022	Disparities in trial enrollment and outcomes of Hispanic adolescent and young adult patients with ALL	Retrospective	Multicenter	Hematologic malignancy	Race/ethnicity, SES, geographic	Household income
Birhiray et al⁴⁶	Blood Advances	2023	Practical strategies for creating diversity, equity, inclusion, and access in cancer clinical research	Perspective/editorial	n/a	n/a	Race/ethnicity	n/a
Improving processes for the collection of data related to the social determinants of health
Fingrut et al⁴⁷	Blood Advances	2023	Race/ethnicity and ancestry data collection process improvement	Retrospective	Single center	BMT/cell therapies	Race/ethnicity	n/a
Fingrut et al⁴⁸	Blood Advances	2023	Socioeconomic status data collection process improvement	Retrospective	Single center	BMT/cell therapies	Race/ethnicity, SES	Neighborhood poverty, insurance status, receipt of financial support for medical or cost-of-living expenses
Interventions to address equity issues
Chou et al⁴⁹	Blood	2018	Investigation of RH-genotype matching to improve use of African-American blood donor inventory	Prospective observational	Single center	Transfusion medicine	Race/ethnicity	n/a
Barker et al⁵⁰	Blood Advances	2020	Optimizing cord blood transplantation to extend allograft access	Retrospective	Single center	BMT/cell therapies	Race/ethnicity	n/a
Qayed et al⁵¹	Blood Advances	2022	Abatacept for GVHD prophylaxis can reduce racial disparities by abrogating the impact of mismatching in unrelated donor transplantation	Clinical trial	Multicenter	BMT/cell therapies	Race/ethnicity	n/a
Bashey et al⁵²	Blood Advances	2023	Close integration of leukemia and transplant services and use of haploidentical donors improves allograft access, but caregiver requirements continue to limit access for Black patients	Retrospective	Single center	BMT/cell therapies	Race/ethnicity	Lack of caregiver support
DeZern et al⁵³	Blood	2023	Alternative donor BMT with posttransplant cyclophosphamide improves allograft access for patients with acquired severe aplastic anemia	Clinical trial	Single center	BMT/cell therapies	Race/ethnicity	n/a
Workforce disparities
King et al⁵⁴	Blood Advances	2020	Gender and caregiving disparities in academic success in hematology	Retrospective	n/a	n/a	Gender	n/a
Moazzam et al⁵⁵	Blood Advances	2020	Gender disparities in question-asking at the 2019 ASH annual meeting	Retrospective	n/a	n/a	Gender	n/a
Syaj et al⁵⁶	Blood Advances	2022	Gender disparities in heme/onc board review lecture series speakers	Retrospective	n/a	n/a	Gender	n/a
Jacobs et al⁵⁷	Blood Advances	2023	Gender disparities in nontrainee hemostasis and thrombosis recognition award recipients	Retrospective	n/a	n/a	Gender	n/a

Authors	Journal	Year	Study summary	Study design	Study site	Disease	Disparities examined	SES measures
Basic science correlates of disparities
Hu et al¹	Blood	2018	Genetic determinants of racial disparities in vitamin B12 levels	Basic science	n/a	Hematopoiesis	Race/ethnicity	n/a
Qian et al²	Blood	2019	Genetic basis for racial disparities in ALL	Basic science	n/a	Hematologic malignancy	Race/ethnicity	n/a
Fillmore et al³	Blood Advances	2021	Genetic basis for racial disparities in multiple myeloma	Basic science	n/a	Hematologic malignancy	Race/ethnicity	n/a
Mittelman et al⁴	Blood	2021	Genetic basis for racial disparities in ALL	Basic science	n/a	Hematologic malignancy	Race/ethnicity	n/a
Health equity in laboratory medicine
Merz et al⁵	Blood	2021	Appeal to stop labeling common phenotypes in non-White populations as abnormal	Perspective/editorial	n/a	Leukocytes, inflammation, immunology	Race/ethnicity	n/a
Merz et al⁶	Blood Advances	2023	Duffy-null phenotype is common among Black people and is associated with lower absolute neutrophil count	Prospective observational	Single center	Leukocytes, inflammation, immunology	Race/ethnicity	n/a
Bagheri et al⁷	Blood Advances	2023	Duffy-null phenotype is common among Black people and is associated with lower absolute neutrophil count	Retrospective	Single center	Leukocytes, inflammation, immunology	Race/ethnicity	n/a
Disease phenotype and outcome differences by patient demographics
Østgård et al⁸	Blood	2018	Association between cohabitation status, treatment, and outcome in patients with AML	Retrospective	Database	Hematologic malignancy	SES	Cohabitation, marital status
Goldstein et al⁹	Blood	2018	Disparities in survival by insurance status in follicular lymphoma	Retrospective	Database	Hematologic malignancy	SES	Insurance status
Ailawadhi et al¹⁰	Blood Advances	2019	Racial disparities in treatment patterns and outcomes among patients with multiple myeloma	Retrospective	Database	Hematologic malignancy	Race/ethnicity	n/a
Fillmore et al¹¹	Blood	2019	Racial differences in survival among patients with multiple myeloma	Retrospective	Database	Hematologic malignancy	Race/ethnicity, SES	Income
Zhang et al¹²	Blood Advances	2020	Impact of single parenthood on cardiopulmonary function in pediatric patients with sickle cell anemia	Prospective observational	Multicenter	Red cell physiology and disorders	SES	Single-parent household
Kim et al¹³	Blood	2020	Racial differences in ITP prevalence and phenotype	Retrospective	Multicenter	Hemostasis, thrombosis, vascular wall biology	Race/ethnicity	n/a
Conneely et al¹⁴	Blood Advances	2021	Racial/ethnic disparities in clinical phenotype, genetics, and survival in pediatric AML	Retrospective	Database	Hematologic malignancy	Race/ethnicity	n/a
Yao et al¹⁵	Blood Advances	2021	Disparities in skeletal toxicity among patients with childhood ALL	Retrospective	Single center	Hematologic malignancy	Race/ethnicity	n/a
Glimelius et al¹⁶	Blood Advances	2021	Marital status affects transplant access and survival for patients with mantel cell lymphoma	Retrospective	Database	Hematologic malignancy	SES	Marital status
Bona et al¹⁷	Blood	2021	Neighborhood poverty and pediatric allogeneic transplant outcomes	Retrospective	Database	BMT and cell therapies	Race/ethnicity, SES	Neighborhood poverty, insurance status
Milrod et al¹⁸	Blood	2021	Skin hyperpigmentation in Black patients receiving treatment with immunomodulatory drugs	Retrospective	Single center	BMT/cell therapies	Race/ethnicity	n/a
Van der Meulen et al¹⁹	Hematology, ASH Education Program	2022	Review of the impact of von Willebrand disease on women	Review	n/a	Hemostasis, thrombosis, vascular wall biology	Gender	n/a
Peres et al²⁰	Blood Advances	2022	Racial disparities in clonal hematopoiesis, tumor markers, and outcomes in patients with multiple myeloma	Retrospective	Single center	Hematologic malignancy	Race/ethnicity	n/a
Datta et al²¹	Blood Advances	2022	Racial disparities in cancer-associated thrombosis	Retrospective	Database	Hemostasis, thrombosis, vascular wall biology	Race/ethnicity	n/a
Faruqi et al²²	Blood Advances	2022	Racial/ethnic disparities in CAR T-cell therapy outcomes	Retrospective	Single center	BMT/cell therapies	Race/ethnicity	n/a
Chaturvedi et al²³	Blood	2022	Racial disparities in relapse risk and response to rituximab in patients with TTP	Retrospective	Multicenter	Hemostasis, thrombosis, vascular wall biology	Race/ethnicity	n/a
Abraham et al²⁴	Blood	2022	Structural racism is a mediator of disparities in AML outcomes	Retrospective	Multicenter	Hematologic malignancy	Race/ethnicity, SES	Structural racism, insurance status
Kittai et al²⁵	Blood Advances	2023	Racial and socioeconomic disparities in CLL/SLL	Retrospective	Database	Hematologic malignancy	Race/ethnicity, SES	Neighborhood poverty
Larkin et al²⁶	Blood Advances	2022	Racial disparities in early death rates, treatment resistance, and survival in Black adolescents and young adults with AML	Retrospective	Multicenter	Hematologic malignancy	Race/ethnicity	n/a
Gangat et al²⁷	Blood Advances	2023	Racial disparities in myelofibrosis phenotype and survival	Retrospective	Multicenter	Hematologic malignancy	Race/ethnicity	n/a
Newman et al²⁸	Blood	2023	Impact of poverty on outcomes for children treated with CD19-directed CAR T-cell therapy	Retrospective	Single center	BMT and cell therapies	Race/ethnicity, SES	Neighborhood poverty, insurance status
Access to care for underserved populations
Bhatt et al²⁹	Blood Advances	2018	Socioeconomic status disparities in treatment patterns among patients with newly diagnosed AML	Retrospective	Database	Hematologic malignancy	Race/ethnicity, SES	Insurance status, median household income
Husson et al³⁰	Blood	2018	Review of unique barriers affecting care delivery and outcomes for adolescents and young adults with hematologic malignancies	Review	n/a	Hematologic malignancy	Age, SES	Education, employment, and financial challenges, social relationship
Keegan et al³¹	Hematology, ASH Education Program	2018	Disparities in clinical trial enrollments for adolescent patients	Review	n/a	n/a	Age, race/ethnicity, SES	Insurance status
Franceschi et al³²	Blood	2019	Access to emergency departments for acute events and identification of sickle cell disease in refugees	Retrospective	Multicenter	Red cell physiology and disorders	Immigration status	n/a
Chino et al³³	Blood Advances	2019	Disparities in place of death for patients with hematologic malignancies	Retrospective	Database	Hematologic malignancy	Race/ethnicity, SES	Marital status, education level
Barker et al³⁴	Blood Advances	2019	Racial disparities in access to HLA-matched unrelated donor transplants	Prospective observational	Single center	BMT/cell therapies	Race/ethnicity	n/a
Webb et al³⁵	Hematology, ASH Education Program	2020	Review of the social aspects of chronic transfusion support	Review	n/a	n/a	SES	Social determinants of health, health literacy
Buchbinder et al³⁶	Hematology, ASH Education Program	2021	Review of psychosocial and financial issues after hematopoietic cell transplantation	Review	n/a	BMT/cell therapies	SES	Social/financial barriers
Hong et al³⁷	Hematology, ASH Education program	2021	Review of access to allogeneic transplantation according to race, geography, and socioeconomics	Review	n/a	BMT/cell therapies	Race/ethnicity, SES	Insurance, education, poverty, employment
Teichman et al³⁸	Blood Advances	2021	Socioeconomic disparities in iron deficiency screening in pregnancy	Retrospective	Database	Red cell physiology and disorders	SES	Neighborhood poverty
Fingrut et al³⁹	Blood Advances	2022	Racial disparities in access to optimal alternative donor allografts	Retrospective	Single center	BMT/cell therapies	Race/ethnicity	n/a
Hussaini et al⁴⁰	Blood Advances	2022	Rural-urban disparities in place of death among patients with hematologic malignancies	Retrospective	Database	Hematologic malignancy	Geographic	n/a
Fingrut et al⁴¹	Blood Advances	2023	Racial disparities in time to allogeneic transplantation	Retrospective	Single center	Hematologic malignancy	Race/ethnicity	n/a
Wolfson et al⁴²	Blood Advances	2023	Neighborhood poverty, health status, and health use after stem cell transplantation	Retrospective	Multicenter	BMT/cell therapies	SES	Neighborhood poverty, annual household income, education
Diversity, equity, and inclusion in clinical trials enrollment
Hantel et al⁴³	Blood Advances	2021	Racial/ethnic disparities in enrollment and demographic reporting requirements in acute leukemia clinical trials	Meta-analysis	Database	Hematologic malignancy	Race/ethnicity	n/a
Kanapuru et al⁴⁴	Blood Advances	2022	Racial/ethnic disparities in multiple myeloma US FDA approval trials	Meta-analysis	Database	Hematologic malignancy	Race/ethnicity	n/a
Muffly et al⁴⁵	Blood Advances	2022	Disparities in trial enrollment and outcomes of Hispanic adolescent and young adult patients with ALL	Retrospective	Multicenter	Hematologic malignancy	Race/ethnicity, SES, geographic	Household income
Birhiray et al⁴⁶	Blood Advances	2023	Practical strategies for creating diversity, equity, inclusion, and access in cancer clinical research	Perspective/editorial	n/a	n/a	Race/ethnicity	n/a
Improving processes for the collection of data related to the social determinants of health
Fingrut et al⁴⁷	Blood Advances	2023	Race/ethnicity and ancestry data collection process improvement	Retrospective	Single center	BMT/cell therapies	Race/ethnicity	n/a
Fingrut et al⁴⁸	Blood Advances	2023	Socioeconomic status data collection process improvement	Retrospective	Single center	BMT/cell therapies	Race/ethnicity, SES	Neighborhood poverty, insurance status, receipt of financial support for medical or cost-of-living expenses
Interventions to address equity issues
Chou et al⁴⁹	Blood	2018	Investigation of RH-genotype matching to improve use of African-American blood donor inventory	Prospective observational	Single center	Transfusion medicine	Race/ethnicity	n/a
Barker et al⁵⁰	Blood Advances	2020	Optimizing cord blood transplantation to extend allograft access	Retrospective	Single center	BMT/cell therapies	Race/ethnicity	n/a
Qayed et al⁵¹	Blood Advances	2022	Abatacept for GVHD prophylaxis can reduce racial disparities by abrogating the impact of mismatching in unrelated donor transplantation	Clinical trial	Multicenter	BMT/cell therapies	Race/ethnicity	n/a
Bashey et al⁵²	Blood Advances	2023	Close integration of leukemia and transplant services and use of haploidentical donors improves allograft access, but caregiver requirements continue to limit access for Black patients	Retrospective	Single center	BMT/cell therapies	Race/ethnicity	Lack of caregiver support
DeZern et al⁵³	Blood	2023	Alternative donor BMT with posttransplant cyclophosphamide improves allograft access for patients with acquired severe aplastic anemia	Clinical trial	Single center	BMT/cell therapies	Race/ethnicity	n/a
Workforce disparities
King et al⁵⁴	Blood Advances	2020	Gender and caregiving disparities in academic success in hematology	Retrospective	n/a	n/a	Gender	n/a
Moazzam et al⁵⁵	Blood Advances	2020	Gender disparities in question-asking at the 2019 ASH annual meeting	Retrospective	n/a	n/a	Gender	n/a
Syaj et al⁵⁶	Blood Advances	2022	Gender disparities in heme/onc board review lecture series speakers	Retrospective	n/a	n/a	Gender	n/a
Jacobs et al⁵⁷	Blood Advances	2023	Gender disparities in nontrainee hemostasis and thrombosis recognition award recipients	Retrospective	n/a	n/a	Gender	n/a

ALL, acute lymphoblastic leukemia; AML, acute myeloid leukemia; BMT, bone marrow transplant; CAR, chimeric antigen receptor; CLL, chronic lymphocytic leukemia; FDA, Food and Drug Administration; GVHD, graft-versus-host disease; heme/onc, hematology/oncology; n/a, not applicable; SES, socioeconomic status; SLL, small lymphocytic lymphoma; TTP, thrombotic thrombocytopenic purpura.

View Large

This Feature Is Available To Subscribers Only